Outcomes
The primary outcome was all-cause mortality among hospitalized patients (inpatient encounters) with SARS-CoV2 infection. We also evaluated intensive care unit (ICU) admission and AKI among hospitalized patients. Further, we examined hospitalization among all encounters (inpatient and outpatient). The primary analysis compared outcomes between patients with a history of cancer to those without a history of cancer. Secondary analyses compared outcomes between patients with specific neoplasm locations (kidney, prostate, bladder, lung, hematological, general genitourinary). Oncologic co-morbidities were determined by ICD-10 codes in patients’ problem lists in the EMR. Patients were included in the specific neoplasm location cohorts regardless of whether the ICD-10 noted the neoplasm as primary, secondary, or unspecified.